NCT06904287View on ClinicalTrials.gov

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Migraine
Interventions
DRUG

Magnesium

Prochlorperazine 10 mg administered as an intravenous push over 2 minutes followed by magnesium 2 g administered as an intravenous bolus over a period of 20 minutes

DRUG

Placebo

Prochlorperazine 10 mg administered as an intravenous push over 2 minutes followed by placebo (normal saline)

Trial Locations (1)

60453

Advocate Christ Medical Center Emergency Department, Oak Lawn

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER